Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate. - Wikidata - awgldk - TriplyDB

Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate.

Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate.

http://www.wikidata.org/entity/Q44599938

about

Interventions for preventing bone disease in kidney transplant recipients Bisphosphonates: mechanism of action and role in clinical practice Efficacy and Safety of Bisphosphonates for Low Bone Mineral Density After Kidney Transplantation: A Meta-Analysis Mineral and bone disorder after kidney transplantation Management of mineral and bone disorder after kidney transplantation.Individualized therapy to prevent bone mineral density loss after kidney and kidney-pancreas transplantation.Skeletal effects of zoledronic acid in an animal model of chronic kidney disease Temporal trends in the incidence, treatment and outcomes of hip fracture after first kidney transplantation in the United States Prevention of fractures after solid organ transplantation: a meta-analysis.Reduced fracture risk with early corticosteroid withdrawal after kidney transplant.Vitamin D in organ transplantation Clinical efficacy and safety of pamidronate therapy on bone mass density in early post-renal transplant period: a meta-analysis of randomized controlled trials.Comparison of mineral quality and quantity in iliac crest biopsies from high- and low-turnover osteoporosis: an FT-IR microspectroscopic investigation.Updated recommendations for the diagnosis and management of osteoporosis: a local perspective Long-term clinical practice experience with cinacalcet for treatment of hypercalcemic hyperparathyroidism after kidney transplantation Potential future uses of calcimimetics in patients with chronic kidney disease.Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications Micro-MR imaging-based computational biomechanics demonstrates reduction in cortical and trabecular bone strength after renal transplantation Effect of a convenient single 90-mg pamidronate dose on biochemical markers of bone metabolism in patients with acute spinal cord injury.Effect of risedronate on bone in renal transplant recipients.Correction of metabolic acidosis with potassium citrate in renal transplant patients and its effect on bone quality Atypical Parathyroid Adenoma Complicated with Protracted Hungry Bone Syndrome after Surgery: A Case Report and Literature Review.Effect of kidney transplantation on bone.Bisphosphonates and bone fractures in long-term kidney transplant recipients Evaluation of nutrient intake in early post kidney transplant recipients Zoledronic acid versus alendronate for the prevention of bone loss after heart or liver transplantation.Skeletal integrity and visceral transplantation Prevalence of Hypercalcaemia in a Renal Transplant Population: A Single Centre Study.Metabolic bone diseases in kidney transplant recipients.Adverse mandibular bone effects associated with kidney disease are only partially corrected with bisphosphonate and/or calcium treatment.Alendronate as an effective treatment for bone loss and vascular calcification in kidney transplant recipients.Post-transplantation osteoporosis.Therapeutic management of post-kidney transplant hyperparathyroidism.Can bisphosphonates play a role in the treatment of children with chronic kidney disease?Osteoporosis after transplantation.Long-term management of the kidney transplant recipient.Bone disease in organ transplant patients: pathogenesis and management.The metabolic and toxicological considerations for immunosuppressive drugs used during pancreas transplantation.Renale osteodystrophie.Bone and mineral disorders after kidney transplantation: therapeutic strategies

P2860

Q24243851-D122D829-1A1E-407D-960A-5FFA3664625E Q24644708-C86B5E3F-E430-4CA2-AF93-86E8A7AD6842 Q26769030-658C7342-22CC-4336-92D5-273175AF1ED6 Q26771398-61B7C28A-383A-46A8-88E0-67C26F57F742 Q30418461-4066C645-D607-46EF-AFFB-A3C978670503 Q33571316-FD71D7D6-45EC-4266-BE0A-F934D0C0C04E Q33779709-221328A2-B74D-4820-A12C-E63D09CC7146 Q33983422-50CCE3CC-25A9-4AB2-B93A-3D718C900446 Q33995388-923DE9C9-87F3-4300-B0F3-BB8E96ED3AB7 Q34069674-6F608F2A-6C9C-4523-B0F0-15716D8B9426 Q34069825-99728968-8D22-4492-8480-74D12FEEEB21 Q34269100-D8483780-7A01-41C7-AD72-97B92EB9A953 Q34590956-B8EC9EF3-01BB-4194-BD16-5E5B23829A2B Q35008617-57C82C2F-2660-4624-B081-B536926939AD Q35226929-CCC5AB02-98CC-405D-8A8A-886068A6B7CA Q35573650-BA6499C1-76F3-4966-B338-56FBD2973B4E Q35740351-7CAAF4F8-D608-4C6D-AC66-75A339D2EC2E Q35773561-96042111-3B31-4C03-BBA9-E3EB900569D1 Q35781312-8F5DD35A-1913-417B-B924-3378B8920518 Q36109164-E7BBFE3F-2014-47B4-82A5-16F012DE0ACC Q36199520-2B736950-CB23-42E3-B59E-90D0614ADD71 Q36320286-AF5476D8-2422-408D-8943-C70E08822146 Q36554790-1E1B2D78-5649-4A8C-9E3C-1B02C6274D6E Q36606360-157060F2-25F2-40E1-ACE8-E0AD1420CDDC Q36611054-D39C1411-FE7D-4F49-8AC1-78A243B75924 Q36666432-3F78EBDE-4A4E-49EF-BEE6-9D57F029D3A5 Q36908631-2F1DFC5B-ED79-4F9E-BDF2-45F22F39369B Q37132254-A0C3510B-A1AA-4DFC-8D01-25BF2BCFA16D Q37195397-710BFDB6-2AB8-400B-A5C5-AE36BCB5414B Q37522423-E4C08C67-A091-49D3-BC60-42C81D2D85B9 Q37622392-B575BAFE-0302-4FFB-9CD3-55C433914320 Q37756580-194CB403-A0EB-415B-8840-7E688426FE0C Q37767247-77050287-5BF1-4672-A009-7CB3D7801003 Q37832414-1C687CF1-7B8D-436A-99D8-7E446EE66ED0 Q37968224-61A344D5-9BAF-4196-8B87-7DA968878C3F Q37978101-EA91C249-B5EC-4649-A523-054926386CF5 Q38018212-9F808AF5-0BA7-44E3-BD21-2CDB22DEF63B Q38043510-1D7CACA8-17C7-452E-A99B-59E55C17BC92 Q38105272-0B3C7499-BAF8-4A11-8F10-3855748FF29E Q38181757-7444AB3C-4525-4121-AA3D-C5CD8402E6E4

P2860

Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate.

http://www.wikidata.org/entity/Q44599938

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Prevention of bone loss in ren ...... al of intravenous pamidronate.

@en

Prevention of bone loss in ren ...... al of intravenous pamidronate.

@nl

type

label

Prevention of bone loss in ren ...... al of intravenous pamidronate.

@en

Prevention of bone loss in ren ...... al of intravenous pamidronate.

@nl

prefLabel

Prevention of bone loss in ren ...... al of intravenous pamidronate.

@en

Prevention of bone loss in ren ...... al of intravenous pamidronate.

@nl

P1433

Q44599938-00B8A035-AEB7-4726-AE40-21937F08F780

P1476

Q44599938-795D6ED6-9E18-4AB1-87F6-F19CCB295E85

P2093

Q44599938-033422B4-501B-4197-B880-B64A5D0F8959

Q44599938-0F869367-9D80-4466-8770-B0F35C446EAC

Q44599938-0F8D0EE7-EB8F-4592-94A4-9F84D799BE6D

Q44599938-2114EDE8-2FD5-4056-B938-8DF42D06BEAB

Q44599938-2D1A742C-FB6B-45CD-A730-25DE8AD1188F

Q44599938-373479B6-19D1-4718-B121-8AE90C019BFB

Q44599938-4DDACE11-6003-4262-8949-45E36FA3C779

Q44599938-56D23CED-6843-4D6C-8438-A729C91318B4

Q44599938-6888095B-20FC-43E9-9AC4-D38E79CA896B

Q44599938-7928729C-CB24-49B4-9FE6-AB7480594ADA

P304

Q44599938-1F58A3AA-DFDF-43A5-9671-1CA3C2B09BBB

P31

Q44599938-84BA696A-E427-4757-A7E3-8F7E56CB7EE3

P356

Q44599938-4E7DB734-1738-4F52-A0FE-640FA5ABF0D4

P433

Q44599938-CAC9048B-9006-48DE-9952-128F76BAE33A

P478

Q44599938-72805D93-C87E-463B-B750-636DA40ECF9E

P577

Q44599938-AC1E6D56-1309-4746-8551-CC6366C35AF0

P698

Q44599938-1A472FA9-E96C-4987-BE64-5F92292116DE

P356

01.ASN.0000087092.53894.80

P1433

Journal of the American Society of Nephrology

P1476

Prevention of bone loss in ren ...... al of intravenous pamidronate.

@en

P2093

Daniel Glicklich

http://www.w3.org/2001/XMLSchema#string

Guodong Wang

http://www.w3.org/2001/XMLSchema#string

Hartmut Malluche

http://www.w3.org/2001/XMLSchema#string

Istvan Bognar

http://www.w3.org/2001/XMLSchema#string

Katherine Figueroa

http://www.w3.org/2001/XMLSchema#string

Larry Burris

http://www.w3.org/2001/XMLSchema#string

Maria Coco

http://www.w3.org/2001/XMLSchema#string

Marie Claude Faugere

http://www.w3.org/2001/XMLSchema#string

Patricia McDonough

http://www.w3.org/2001/XMLSchema#string

Peter Durkin

http://www.w3.org/2001/XMLSchema#string

P304

2669-2676

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/01.ASN.0000087092.53894.80

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2003-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14514747

http://www.w3.org/2001/XMLSchema#string